Aminobenzoic acids and derivatives
Aobchem 3 5-Difluoro-N-methylbenzamide | ≥97% | CAS 948710-28-9 | C8H7F2NO | 10g
3 5-Difluoro-N-methylbenzamide | ≥97% | CAS 948710-28-9 | C8H7F2NO | 10g
Aobchem N-cyclopentyl-3-methylbenzamide | 95% | CAS 349403-64-1 | C13H17NO | 500mg
N-cyclopentyl-3-methylbenzamide | 95% | CAS 349403-64-1 | C13H17NO | 500mg
Aobchem 2-Fluoro-4-methylbenzamide | ≥95% | CAS 886761-61-1 | C8H8FNO | 10g
2-Fluoro-4-methylbenzamide | ≥95% | CAS 886761-61-1 | C8H8FNO | 10g
Aobchem N-cyclopropyl-4-nitrobenzamide | ≥95% | CAS 88229-21-4 | C10H10N2O3 | 5g
N-cyclopropyl-4-nitrobenzamide | ≥95% | CAS 88229-21-4 | C10H10N2O3 | 5g
Aobchem 2-Bromo-5-methylbenzamide | ≥97% | CAS 101421-61-8 | C8H8BrNO | 10g
2-Bromo-5-methylbenzamide | ≥97% | CAS 101421-61-8 | C8H8BrNO | 10g
Aobchem N-ethyl-3-nitrobenzamide | ≥95% | CAS 26819-11-4 | C9H10N2O3 | 5g
N-ethyl-3-nitrobenzamide | ≥95% | CAS 26819-11-4 | C9H10N2O3 | 5g
Medchemexpress LLC Naltriben mesylate | 122517-78-6 | 99.7% | 511.59 g/mol | C27H29NO7S | 5 MG
Naltriben mesylate is the methanesulfonate salt of naltriben, a selective δ2-opioid receptor antagonist and TRPM7 activator used in biochemical and pharmacological research. The compound is supplied as a white to off-white solid and is accompanied by a datasheet and certificate of analysis for identity and quality assurance.
- Selective δ2-opioid receptor antagonist and TRPM7 activator.
- High purity; LCMS purity 99.7% per COA.
- Provided as a mesylate salt for improved stability and handling.
- Characterized molecular formula C27H29NO7S and molecular weight 511.59 g/mol.
- Available in small research quantities suitable for laboratory assays.
- White to off-white solid with analytical data consistent with structure.
Apexbio Technology LLC Delavirdine mesylate 147221-93-0 50mg
Delavirdine mesylate (CAS 147221-93-0) is a small-molecule inhibitor targeting HIV-1 reverse transcriptase It is designed to selectively inhibit the enzymatic activity of HIV-1 reverse transcriptase thereby disrupting viral DNA synthesis and impeding HIV replication Delavirdine mesylate exerts its biological activity primarily through direct binding to an allosteric site on HIV-1 reverse transcriptase In biochemical studies delavirdine mesylate demonstrates inhibitory activity against HIV-1 reverse transcriptase with an IC50 value of 0 26 M Based on these pharmacological properties delavirdine mesylate holds research potential in antiviral assays HIV resistance studies and mechanistic investigations into NNRTI-related enzyme inhibition
Apexbio Technology LLC Danofloxacin Mesylate 119478-55-6 1g
Danofloxacin Mesylate (119478-55-6) is a small-molecule inhibitor targeting bacterial DNA gyrase and topoisomerase IV It is designed to inhibit these enzymes thereby impeding bacterial DNA replication and transcription Danofloxacin Mesylate exerts its biological activity primarily through inhibition of bacterial DNA gyrase and topoisomerase IV In microbiological assays Danofloxacin demonstrates antibacterial inhibition with a minimum inhibitory concentration (MIC90) of approximately 0 28 M Based on these pharmacological properties Danofloxacin Mesylate holds research potential in veterinary antimicrobial studies investigation of bacterial resistance mechanisms and comparative evaluation of antimicrobial activity
Medchemexpress LLC Delavirdine mesylate | 147221-93-0 | MFCD00866948 | 552.67 | C23H32N6O6S2 | 50 MG
Delavirdine mesylate is the mesylate salt of delavirdine, a non-nucleoside reverse transcriptase inhibitor (NNRTI) provided for research and analytical applications. It is supplied as a solid with defined composition and molecular weight for use in in vitro studies of HIV-1 reverse transcriptase. Not for human or clinical use.
- CAS registry number: 147221-93-0.
- Molecular formula: C23H32N6O6S2.
- Molecular weight: 552.67.
- Physical form: solid; appearance white to yellow.
- Available pack sizes: 5 mg, 10 mg, 50 mg, 100 mg, 200 mg.
- Intended use: for research and analytical applications only; not for human use.
Apexbio Technology LLC Eprosartan Mesylate 144143-96-4 10mM (in 1mL DMSO)
Eprosartan Mesylate is a small-molecule antagonist targeting the angiotensin II AT1 receptor It is designed to selectively inhibit the AT1 receptor subtype thereby modulating vasoconstriction and aldosterone secretion mechanisms in cardiovascular systems Eprosartan Mesylate exerts its biological activity primarily through competitive binding to AT1 receptors interfering with angiotensin II action In studies using rat and human adrenal cortical membranes Eprosartan Mesylate demonstrates inhibitory activity with IC50 values of approximately 9 2 nM and 3 9 nM respectively Based on these pharmacological properties Eprosartan Mesylate holds research potential in angiotensin II-mediated signal transduction pathways hypertension models and related cardiovascular diseases
Aobchem (2 2-Difluoro-6-methylbenzo[d][1 3]dioxol-4-yl)boronic acid | 95% | C8H7BF2O4 | 1g
(2 2-Difluoro-6-methylbenzo[d][1 3]dioxol-4-yl)boronic acid | 95% | C8H7BF2O4 | 1g
Aobchem 5-Bromo-2 2-difluorobenzo[d][1 3]dioxole-4-carbaldehyde | 97% | CAS 2631058-90-5 | C8H3BrF2O3 | 10g
5-Bromo-2 2-difluorobenzo[d][1 3]dioxole-4-carbaldehyde | 97% | CAS 2631058-90-5 | C8H3BrF2O3 | 10g
Aobchem Ethyl 2 3-difluoro-6-methoxybenzoate | 97% | CAS 773139-04-1 | C10H10F2O3 | 500mg
Ethyl 2 3-difluoro-6-methoxybenzoate | 97% | CAS 773139-04-1 | C10H10F2O3 | 500mg
Aobchem 7-Bromo-4-methylbenzo[d]thiazol-2-amine | 97% | CAS 1157454-73-3 | C8H7BrN2S | 250mg
7-Bromo-4-methylbenzo[d]thiazol-2-amine | 97% | CAS 1157454-73-3 | C8H7BrN2S | 250mg